辉瑞公司表示,比利时法院近期就欧盟成员国Comirnaty疫苗采购合同作出的裁决,将对企业未来每股收益和现金流产生积极推动作用。这一司法裁定为公司的财务前景提供了有力支撑。
根据预备声明披露,该判决确认了疫苗供应协议的法律效力,有助于稳定辉瑞在欧洲市场的业务预期。公司强调,此项进展将进一步提升其财务稳健性,为股东创造长期价值。
辉瑞公司表示,比利时法院近期就欧盟成员国Comirnaty疫苗采购合同作出的裁决,将对企业未来每股收益和现金流产生积极推动作用。这一司法裁定为公司的财务前景提供了有力支撑。
根据预备声明披露,该判决确认了疫苗供应协议的法律效力,有助于稳定辉瑞在欧洲市场的业务预期。公司强调,此项进展将进一步提升其财务稳健性,为股东创造长期价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.